Approvals/CIMA-AEMPS/APRETUDE 600 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

Approved

STANDARD

APRETUDE 600 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

Viiv Healthcare B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 8fbf9d503b1108fc
Drug Cima Aemps Name: APRETUDE 600 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Register Number: 1231760002
Holder Company Name: Viiv Healthcare B.V.
Marketing Company Name: Laboratorios Viiv Healthcare S.L.
Holder Company Detail Path: /organization/viiv-healthcare-bv
Authorization Date: 2023-09-22
Dosage Form: SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Dose: 600 MG
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Viiv Healthcare B.V.
Company Detail Path: /organization/viiv-healthcare-bv

CABOTEGRAVIR

600 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 22, 2023

Approval ID

8fbf9d503b1108fc

Type

Standard